Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease

Amyloid-β antibodies were modified to incorporate trans -cyclooctene functional groups. Radiolabeled copper-64 probes, which can cross the blood–brain barrier and contain a 1,2,4,5-tetrazine functional group, react with the modified antibodies.